vanadates has been researched along with Leukemia L 1210 in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Böhmerle, K; Martins, C; McNeill, JH; Orvig, C; Polishchuk, E; Thompson, KH; Toleikis, P; Tse, J; Yuen, V | 1 |
| Martins, C; McNeill, JH; Mohammadi, K; Orvig, C; Patrick, BO; Polishchuk, E; Storr, T; Thompson, KH; Yuen, VG | 1 |
| Capolongo, L; Ciomei, M; Geroni, C; Grandi, M; Melegaro, G; Pastori, W; Pennella, G | 1 |
| Bronte, V; Collavo, D; Macino, B; Mandruzzato, S; Rosato, A; Zambon, A; Zanovello, P | 1 |
| Choi, MU; Lee, SY; Yeo, EJ | 1 |
| Djordjevic, C; Wampler, GL | 1 |
6 other study(ies) available for vanadates and Leukemia L 1210
| Article | Year |
|---|---|
Complementary inhibition of synoviocyte, smooth muscle cell or mouse lymphoma cell proliferation by a vanadyl curcumin complex compared to curcumin alone.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Blood Glucose; Cell Division; Cell Line; Cell Line, Tumor; Cell Survival; Curcumin; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Drug Synergism; Growth Inhibitors; Hypoglycemic Agents; Leukemia L1210; Male; Mice; Molecular Structure; Muscle, Smooth, Vascular; Rabbits; Rats; Rats, Wistar; Synovial Membrane; Vanadates | 2004 |
Synthesis and characterization of dual function vanadyl, gallium and indium curcumin complexes for medicinal applications.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Crystallography, X-Ray; Curcumin; Diabetes Mellitus, Experimental; Gallium; Indium; Leukemia L1210; Male; Mice; Rats; Rats, Wistar; Vanadates | 2005 |
Decreased tyrosine phosphorylation in tumour cells resistant to FCE 24517 (tallimustine).
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Colonic Neoplasms; Distamycins; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Enzyme Inhibitors; Humans; Leukemia L1210; Mice; Neoplasm Proteins; Nitrogen Mustard Compounds; Phosphorylation; Protein Tyrosine Phosphatases; Protein-Tyrosine Kinases; Sensitivity and Specificity; Tumor Cells, Cultured; Tyrosine; Vanadates | 1995 |
Protein tyrosine kinases and phosphatases control apoptosis induced by extracellular adenosine 5'-triphosphate.
Topics: Adenosine Triphosphate; Animals; Apoptosis; Blotting, Western; Cell Line; DNA Damage; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Genistein; Homeostasis; Isoflavones; Leukemia L1210; Mast-Cell Sarcoma; Mice; Phosphotyrosine; Protein Tyrosine Phosphatases; Protein-Tyrosine Kinases; Tumor Cells, Cultured; Vanadates | 1996 |
Phospholipase D activity in L1210 cells: a model for oleate-activated phospholipase D in intact mammalian cells.
Topics: ADP-Ribosylation Factors; Animals; Cell Differentiation; Dose-Response Relationship, Drug; Enzyme Activation; Fatty Acids, Unsaturated; GTP-Binding Proteins; Guanosine 5'-O-(3-Thiotriphosphate); HL-60 Cells; Humans; Leukemia L1210; Melitten; Mice; Oleic Acid; Phospholipase D; Tetradecanoylphorbol Acetate; Vanadates | 1998 |
Antitumor activity and toxicity of peroxo heteroligand vanadates(V) in relation to biochemistry of vanadium.
Topics: Animals; Antineoplastic Agents; Leukemia L1210; Mice; Structure-Activity Relationship; Vanadates; Vanadium | 1985 |